We are monitoring the impact of COVID-19 on North America IVD Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 122
Share on
Share on

North America In-Vitro Diagnostics Market Research Report - Segmented By Product, By Technology, By Application & By Country (United States, Canada, Mexico & Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 122
Pages: 145

North America In-Vitro Diagnostics Market Size (2021 to 2026)

The size of the North American IVD Market was valued at USD 25.9 billion in 2020 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 4.7% during the forecast period. Within North America, the United States IVD Market is expected to occupy the majority of the shares.

Growing prevalence for early diagnosis of diseases, increasing incidences of infectious and chronic diseases, and adopting point-of-care testing devices for accurate results in very little time are majorly driving the growth of the North American In-Vitro Diagnostics Market. In addition, the trend towards personalized medicines, rise in the investments in hospitals and clinics by government and non-government organizations, and growth in the scale of diagnostic centers, along with the increasing flow of patients, are expected to fuel the North American IVD market.

Adopting the latest technologies and the launch of innovative products favoring the end-users in the medical sector is certainly to create growth opportunities for the market. Along with this, rising awareness over the availability of different treatment procedures for various diseases among individuals and ongoing research on the development of new devices in concern towards people’s safety and adequate support from the private sectors through investments are lavishing the market's demand in North America.

However, the high cost for installation and maintenance of the equipment used in the diagnostic centers is quietly restricting the demand of the in-vitro diagnostics market in North America. Lack of standardization is one more factor hindering the growth rate of the market. The dearth of skilled people in operating the devices more accurately and analyzing the reports has remained challenging for the market players. Frequent changes in the economic strategies may also negatively impact the market's growth rate in North America.

The U.S. In-Vitro Diagnostics Market:

The United States has the largest In-Vitro diagnostics market in the world. Continuous awareness and product innovations are the factors behind the leading market. In the United States, section 210 of the Federal Food, Drug and cosmetic act says that the diagnostics products are medical devices and biological product subjects.  

The use of point-of-care (POC) diagnostics, high occurrence of chronic diseases, heart diseases, asthma, diabetes, and the Covid-19 in 2020 are majorly boosting up the demand of the market. These diseases are responsible for the high mortality rate in the United States. The use of In-vitro diagnostics is feasible in managing chronic conditions. Furthermore, advances in DNA sequencing, growing demand for diagnostic devices, customers healthcare spending, and government funds will increase the business of the U.S. In-Vitro Diagnostics Market in the forecast period. 

This research report on the North American IVD Market has been segmented and sub-segmented into the following categories:

By Product:

  • Instruments
  • Reagents and Kits
  • Software

By Technology:

  • Clinical Chemistry
  • Hematology
  • Immunoassays
  • Coagulation and Hemostasis
  • Molecular Diagnostics
  • Microbiology
  • Other IVD technologies

By Application:

  • Diabetes
  • Infectious Diseases
  • Oncology/Cancer
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing
  • HIV

By Country:

  • The United States
  • Canada
  • Rest of North America

Geographically, North America is the largest market accounting for a share of around 37% in the global IVD market owing to the growing prevalence of chronic diseases such as cancer and respiratory diseases. Within North America, United States is the largest market for In-Vitro diagnostics accounting for a share of XX%. At the same time, Canada is estimated to be the fastest-growing with a healthy CAGR.


Companies holding the majority of the shares in the North American IVD Market profiled in the report are Abbott Laboratories, Johnson and Johnson, Siemens Healthcare, Becton Dickinson, Roche Diagnostic, Beckman Coulter Inc., Biomérieux, Ortho Clinical Diagnostics, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Sysmex Corporation & Thermo Fisher Scientific, Inc.

  1. Introduction

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                           

                1.4 General Study Assumptions                                                                

  1. Research Methodology

                2.1 Introduction                                                                              

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                            

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                     

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

  1. Overview

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                               

  1. Market Segmentation

                5.1 By Product                                                                  

                                5.1.1 Instruments                                                           

                                5.1.2 Reagents and Kits                                                 

                                5.1.3 Software                                                 

                5.2 By Technology                                                                          

                                5.2.1 Clinical Chemistry                                                

                                5.2.2 Hematology                                                           

                                5.2.3 Immunoassays                                                      

                                5.2.4 Coagulation and Hemostasis                                                           

                                5.2.5 Molecular Diagnostics                                                        

                                5.2.6 Microbiology                                                          

                                5.2.7 Other IVD technologies                                                     

                5.3 By Application                                                                           

                                5.3.1 Diabetes                                                  

                                5.3.2 Infectious Diseases                                                             

                                5.3.3 Oncology/Cancer                                                 

                                5.3.4 Cardiology                                                               

                                5.3.5 Nephrology                                                            

                                5.3.6 Autoimmune Diseases                                                       

                                5.3.7 Drug Testing                                                           

                                5.3.8 HIV                                                             

  1. Geographical Analysis

                                6.1 Introduction                                                              

                                6.2 United States                                                            

                                6.3 Canada                                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                      

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                               

                                7.2.5 Competitive Rivalry within the Industry                                                      

  1. Market Leaders' Analysis

                8.1 Abbott Laboratories                                                               

                                8.1.1 Overview                                                

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                            

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Johnson and Johnson                                                                             

                8.3 Siemens Healthcare                                                                

                8.4 Becton Dickinson                                                                     

                8.5 Roche Diagnostics                                                                    

                8.6 Beckman Coulter Inc.                                                                             

                8.7 Biomérieux                                                                

                8.8 Ortho Clinical Diagnostics, Inc.                                                                           

                8.9 Bio-Rad Laboratories, Inc.                                                                    

                8.10 Danaher Corporation                                                                           

                8.11 Sysmex Corporation                                                                             

                8.12 Thermo Fisher Scientific, Inc.                                                                            

  1. Competitive Landscape

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                        

                9.3 Agreements, collaborations and Joint Ventures                                                                          

                9.4 New Product Launches                                                                          

  1. Expert Opinions

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 


  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Global In-Vitro Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  2. North America Global In-Vitro Diagnostics Market, By Type, From 2021 to 2026 (USD Million)    
  3. North America Instruments Market, By Region, From 2021 to 2026 (USD Million)                                                    
  4. North America Reagents and Kits Market, By Region, From 2021 to 2026 (USD Million) 
  5. North America Software Market, By Region, From 2021 to 2026 (USD Million)   
  6. North America Clinical Chemistry Market, By Region, From 2021 to 2026 (USD Million) 
  7. North America Hematology Market, By Region, From 2021 to 2026 (USD Million)                                                    
  8. North America Immunoassays Market, By Region, From 2021 to 2026 (USD Million)                                               
  9. North America Coagulation and Hemostasis Market, By Region, From 2021 to 2026 (USD Million)                                                    
  10. North America Molecular Diagnostics Market, By Region, From 2021 to 2026 (USD Million)                                                 
  11. North America Microbiology Market, By Region, From 2021 to 2026 (USD Million)                                                  
  12. North America Other IVD technologies Market, By Region, From 2021 to 2026 (USD Million)      
  13. North America Diabetes Market, By Region, From 2021 to 2026 (USD Million)   
  14. North America Infectious Diseases Market, By Region, From 2021 to 2026 (USD Million)                                                       
  15. North America Oncology/Cancer Market, By Region, From 2021 to 2026 (USD Million)  
  16. North America Cardiology Market, By Region, From 2021 to 2026 (USD Million)                                                       
  17. North America Nephrology Market, By Region, From 2021 to 2026 (USD Million)                                                     
  18. North America Autoimmune Diseases Market, By Region, From 2021 to 2026 (USD Million)                                                
  19. North America Drug Testing Market, By Region, From 2021 to 2026 (USD Million)                                                    
  20. North America HIV Market, By Region, From 2021 to 2026 (USD Million)                                                      
  21. United States Market, By Product, From 2021 to 2026 (USD Million)      
  22. United States Market, By Technology, From 2021 to 2026 (USD Million)                                                       
  23. United States Market, By Application, From 2021 to 2026 (USD Million)                                                       
  24. Canada Market, By Product, From 2021 to 2026 (USD Million)  
  25. Canada Market, By Technology, From 2021 to 2026 (USD Million)                                                   
  26. Canada Market, By Application, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample